Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Integrating stereotactic radiotherapy and systemic therapies.
Palumbo I, Pasqualetti F, Delishaj D, Gonnelli A, Aristei C, Borghesi S, Pirtoli L, Belgioia L, Arcangeli S. Palumbo I, et al. Among authors: delishaj d. Rep Pract Oncol Radiother. 2022 May 19;27(2):310-317. doi: 10.5603/RPOR.a2022.0020. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 36299395 Free PMC article. Review.
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology.
Pasqualetti F, Pace A, Gonnelli A, Villani V, Cantarella M, Delishaj D, Vivaldi C, Molinari A, Montrone S, Pellerino A, Franchino F, Baldaccini D, Lombardi G, Lolli I, Catania F, Bazzoli E, Morganti R, Fabi A, Zagonel V, Bocci G, Fabrini MG, Rudà R, Soffietti R, Paiar F. Pasqualetti F, et al. Among authors: delishaj d. Am J Clin Oncol. 2018 Dec;41(12):1272-1275. doi: 10.1097/COC.0000000000000464. Am J Clin Oncol. 2018. PMID: 29782366
Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy.
Pasqualetti F, Gonnelli A, Cantarella M, Delishaj D, Molinari A, Ortenzi V, Carbone F, Montrone S, Ursino S, Franceschi S, Morganti R, Orlandi P, Di Desidero T, Mazzanti CM, Zavaglia K, Naccarato AG, Bocci G, Paiar F. Pasqualetti F, et al. Among authors: delishaj d. Invest New Drugs. 2018 Apr;36(2):340-345. doi: 10.1007/s10637-017-0516-2. Epub 2017 Sep 30. Invest New Drugs. 2018. PMID: 28965273
Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit?
Laliscia C, Delishaj D, Fabrini MG, Gonnelli A, Morganti R, Perrone F, Tana R, Paiar F, Gadducci A. Laliscia C, et al. Among authors: delishaj d. J Contemp Brachytherapy. 2016 Dec;8(6):512-517. doi: 10.5114/jcb.2016.64511. Epub 2016 Dec 9. J Contemp Brachytherapy. 2016. PMID: 28115957 Free PMC article.
High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses - 14 years of single-centre experience.
Soatti CP, Delishaj D, D'Amico R, Frigerio C, Fumagalli IC, Bonsignore F, Sangalli G, Declich F, Arcangeli S, Ardizzoia A, Colombo A. Soatti CP, et al. Among authors: delishaj d. J Contemp Brachytherapy. 2020 Dec;12(6):533-539. doi: 10.5114/jcb.2020.101685. Epub 2020 Dec 16. J Contemp Brachytherapy. 2020. PMID: 33437300 Free PMC article.
25 results